Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 12Anemia, Refractory, with Excess of Blasts 11Myelodysplastic Syndromes 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasms 7Anemia, Aplastic 6Venous Thromboembolism 5Myeloproliferative Disorders 5Lymphoma, Non-Hodgkin 5Leukemia, Lymphocytic, Chronic, B-Cell 5Multiple Myeloma 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Hodgkin Disease 4Hematologic Neoplasms 4Fanconi Anemia 4Anemia 4Pulmonary Embolism 3Primary Myelofibrosis 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Leukemia, Myeloid, Accelerated Phase 3Congenital Bone Marrow Failure Syndromes 3Burkitt Lymphoma 3Blast Crisis 3Anemia, Sickle Cell 3Venous Thrombosis 2Recurrence 2Lymphoma, Large B-Cell, Diffuse 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sepsis × Classical hematology × 30 days × Clear all
NCT07277387 2026-06-15

Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia

Instituto de Investigación Biomédica de Salamanca

Recruiting
350 enrolled
Classical hematologyOther hematologic neoplasm

Shock, Septic, Sepsis, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡